Once viewed as hopelessly incurable disorders and the dustbin for careers in academic
medicine, the polycystic kidney diseases have emerged as prime targets of …

Antecedentes: En la poliquistosis renal autosómica dominante (PQRAD), la hematuria
macroscópica por la rotura de quistes renales es una manifestación habitual, que puede ser …

Table 2 lists the investigations used in assessing ADPKD patients. New unified diagnostic
ultrasound criteria for at-risk PKD1 and PKD2 individuals have recently been reported …

Abstract Background/Aims: In this retrospective study we aimed to compare the effect of
tranexamic acid (TXA) vs etamsylate, two hemostatic agents, on hematuria duration in …

A 41‐year‐old woman with autosomal dominant polycystic kidney disease had chronic
kidney disease class IV. She presented 10 days postpartum with a 4‐day history of severe …

We describe a successful treatment of a severe, persistent bleeding from both kidneys in a
patient with autosomal dominant polycystic kidney disease (ADPKD) with tranexamic acid …

TORREGROSA, José V. et al. Tratamiento eficaz de la arteriolopatía urémica calcificante
con bifosfonatos. Nefrología (Madr.)[online]. 2012, vol. 32, n. 3, pp. 329-334. ISSN 0211 …

Autosomal dominant polycystic kidney disease (PKD) is the most prevalent hereditary
disorder in this country and a common cause of chronic renal failure. Patients frequently …

Introduction: Pre-existing renal lesions predispose kidneys to effects of otherwise
insignificant blunt trauma, and may uncommonly present as an incidental finding in the …

No benefit accrues from the prophylactic administration of desmopressin to limit surgical
bleeding in patients with normal hemostasis. This applies to many different kinds of surgical …